Yi‐Chiung Hsu

2.6k citations
78 papers · 1.5k indexed · h-index 22
Topics
Thyroid Cancer Diagnosis and Treatment (13 papers)Lung Cancer Treatments and Mutations (10 papers)Cancer Genomics and Diagnostics (8 papers)
Partner nations
TaiwanUnited StatesJapan

In The Last Decade

Yi‐Chiung Hsu

75 papers receiving 1.5k citations

Peers

Yi‐Chiung Hsu
Comparison fields: 5 of 135
  • Molecular Biology 571
  • Oncology 391
  • Endocrinology, Diabetes and Metabolism 278
  • Cancer Research 270
  • Immunology 237
Replace Guanghua Luo with:
Guanghua Luo China
Marco Ruggiero Italy
Satoshi Iino Japan
Lisa F. Lincz Australia
Yuki Tanaka Japan
Qiang Li China
Fei Liu China
Yi‐Chen Li Taiwan
Koji Ikeda Japan
Yi‐Chiung Hsu relative to Guanghua Luo China Guanghua Luo's profile →
Citations per field
00.5×1.6×
Guanghua Luo · 1×
Citations per year

Countries citing papers authored by Yi‐Chiung Hsu

Since Specialization
Citations

This map shows the geographic impact of Yi‐Chiung Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Chiung Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Chiung Hsu more than expected).

Fields of papers citing papers by Yi‐Chiung Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi‐Chiung Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Chiung Hsu. The network helps show where Yi‐Chiung Hsu may publish in the future.

Co-authorship network of co-authors of Yi‐Chiung Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Yi‐Chiung Hsu. A scholar is included among the top collaborators of Yi‐Chiung Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi‐Chiung Hsu. Yi‐Chiung Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 2
4 4
5 2
6 4
7 1
8 12
9 4
10 14
11 12
12 15
13 26
14 38
15 32
16 121
17 38
18 24
19 42
20 46

About Yi‐Chiung Hsu

Yi‐Chiung Hsu is a scholar working on Cancer Research, Endocrinology, Diabetes and Metabolism and Oncology, having authored 78 papers that have together received 1.5k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (13 papers), Lung Cancer Treatments and Mutations (10 papers) and Cancer Genomics and Diagnostics (8 papers). The work is most often cited by research in Cancer Research (270 citations), Endocrinology, Diabetes and Metabolism (278 citations) and Oncology (391 citations). Yi‐Chiung Hsu has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Shih‐Ping Cheng, Chien‐Liang Liu, Jie-Jen Lee, Shih‐Yuan Huang, Hubert Serve, Peter Besmer, Yuan-Ching Chang, Ming-Jen Chen, Pan‐Chyr Yang and Jie‐Jen Lee. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026